COMEDK 2007 MCQ Answer 66

on with 0 comments



The correct answer is D

The combination of amphotericin B and intralipid should not be given to patients

  • Intralipid does not decrease the renal toxicity and subjective side effects associated with intravenous amphotericin B at a dose of 0.75 mg/kg/day in neutropenic cancer patients
  • Use of amphotericin B in intralipid 20% can be associated with transient pulmonary toxicity, possibly related to fat overload
  • On the basis of published data, amphotericin B and intralipid 20% should be regarded as chemically incompatible



Category:

POST COMMENT

0 comments:

Post a Comment

Is there something you wish to add? Have something to say? Feel free to leave a comment.